Medicamen Biotech Limited (MEDICAMEQ) — Net Asset Quality Index
Medicamen Biotech Limited (MEDICAMEQ) has a Net Asset Quality Index of 75.0% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs3.67 Billion minus total liabilities of Rs916.99 Million yields net assets of Rs2.75 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Medicamen Biotech Limited's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medicamen Biotech Limited Net Asset Quality Index Over Time (2006–2025)
This chart shows how Medicamen Biotech Limited's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the index stands at 75.0%, representing net assets of Rs2.75 Billion against total assets of Rs3.67 Billion INR. See Medicamen Biotech Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Medicamen Biotech Limited (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Medicamen Biotech Limited from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Medicamen Biotech Limited.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.7% | Rs2.13 Billion | Rs2.97 Billion | Rs841.04 Million | ▲ +1.4 pp |
| 2024 | 70.3% | Rs2.07 Billion | Rs2.95 Billion | Rs875.67 Million | ▲ +0.8 pp |
| 2023 | 69.4% | Rs1.93 Billion | Rs2.79 Billion | Rs851.03 Million | ▲ +4.5 pp |
| 2022 | 64.9% | Rs1.46 Billion | Rs2.26 Billion | Rs792.24 Million | ▼ -3.6 pp |
| 2021 | 68.5% | Rs1.33 Billion | Rs1.94 Billion | Rs611.18 Million | ▲ +1.6 pp |
| 2020 | 66.9% | Rs1.21 Billion | Rs1.81 Billion | Rs600.66 Million | ▲ +3.4 pp |
| 2019 | 63.4% | Rs866.34 Million | Rs1.37 Billion | Rs499.59 Million | ▼ 0.0 pp |
| 2018 | 63.5% | Rs746.08 Million | Rs1.18 Billion | Rs429.43 Million | ▲ +27.0 pp |
| 2017 | 36.5% | Rs267.81 Million | Rs734.01 Million | Rs466.20 Million | ▲ +6.6 pp |
| 2016 | 29.8% | Rs179.09 Million | Rs600.18 Million | Rs421.09 Million | ▲ +4.8 pp |
| 2015 | 25.0% | Rs171.85 Million | Rs686.63 Million | Rs514.78 Million | ▼ -0.6 pp |
| 2014 | 25.6% | Rs165.38 Million | Rs645.79 Million | Rs480.41 Million | ▲ +1.5 pp |
| 2013 | 24.1% | Rs157.17 Million | Rs652.34 Million | Rs495.17 Million | ▼ -5.1 pp |
| 2012 | 29.2% | Rs201.01 Million | Rs689.07 Million | Rs488.06 Million | ▲ +0.0 pp |
| 2011 | 29.2% | Rs204.12 Million | Rs700.18 Million | Rs496.06 Million | ▲ +1.0 pp |
| 2010 | 28.2% | Rs162.61 Million | Rs576.83 Million | Rs414.22 Million | ▼ -0.1 pp |
| 2009 | 28.3% | Rs129.60 Million | Rs458.11 Million | Rs328.50 Million | ▲ +5.9 pp |
| 2008 | 22.4% | Rs115.83 Million | Rs517.72 Million | Rs401.88 Million | ▲ +0.7 pp |
| 2007 | 21.7% | Rs100.73 Million | Rs464.17 Million | Rs363.44 Million | ▼ -3.6 pp |
| 2006 | 25.3% | Rs85.67 Million | Rs338.18 Million | Rs252.51 Million | — |